Clinical trials
Phase 2 Intestinal Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Bausch Health Americas, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Facet Biotech | 1 |
| Furiex Pharmaceuticals, Inc | 1 |
| Hoffmann-La Roche | 1 |
| ImmusanT, Inc. | 1 |
| Kyowa Kirin, Inc. | 1 |
| Northwell Health | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intestinal Diseases | 15 |
| Digestive System Diseases | 10 |
| Gastrointestinal Diseases | 10 |
| Colonic Diseases | 6 |
| Inflammatory Bowel Diseases | 4 |
| Neoplasms | 4 |
| Colitis | 3 |
| Colorectal Neoplasms | 3 |
| Crohn Disease | 3 |
| Digestive System Neoplasms | 3 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.